BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/7/2025 6:39:58 AM | Browse: 59 | Download: 120
 |
Received |
|
2025-05-26 12:40 |
|
Peer-Review Started |
|
2025-05-26 12:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-29 23:58 |
|
Revised |
|
2025-06-04 07:16 |
|
Second Decision |
|
2025-07-17 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-17 05:07 |
|
Articles in Press |
|
2025-07-17 05:07 |
|
Publication Fee Transferred |
|
2025-06-06 07:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-04 01:42 |
|
Publish the Manuscript Online |
|
2025-08-07 06:39 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Geng-Chen Li, Zhi-Yuan Yao, Hong-Sen Mao and Zheng-Xiang Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zheng-Xiang Han, PhD, Professor, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. xzpxlgc@163.com |
| Key Words |
Hepatocellular carcinoma; Triglyceride-glucose index; Camrelizumab; Lenvatinib; Efficacy; Safety |
| Core Tip |
Primary liver cancer ranks among the most prevalent and lethal malignancies worldwide. Although combination therapies have improved treatment options, overall prognosis remains unsatisfactory. The triglyceride-glucose index, a simple surrogate marker of insulin resistance, has recently been associated with tumor progression and immune modulation. This retrospective study evaluates the prognostic significance of the triglyceride-glucose index in patients with advanced hepatocellular carcinoma receiving immunotherapy combined with targeted therapy, offering insights into its potential role in risk stratification and clinical decision-making. |
| Publish Date |
2025-08-07 06:39 |
| Citation |
<p>Li GC, Yao ZY, Mao HS, Han ZX. Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy. <i>World J Gastroenterol</i> 2025; 31(30): 109863</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i30/109863.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i30.109863 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
